Vimarsana
Biggest News Aggregation in the World

Page 2 - Assay Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assay Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assay Services Today - Breaking & Trending Today

Global Stem Cell Banking Market to Surpass US$ 17,912.71 Million by 2030 - Vimarsana News

Global Stem Cell Banking Market to Surpass US$ 17,912.71 Million by 2030

/PRNewswire/ -- According to Coherent Market Insights, the global stem cell banking market is estimated to be valued at US$ 4,483.31 million in 2022 and is...

Global Protein Expression Market (2021 to 2028) - Vimarsana News

Global Protein Expression Market (2021 to 2028)

Dublin, Oct. 13, 2021 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...

Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research™ - Vimarsana News

Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research™

Share this article Share this article Jersey City, N.J., June 9, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Proteomics Market" By Reagent (Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents & Others), By Instrumentation Technology (X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation & Others), By Software and Service (Core Proteomics Services and Bioinformatics Software and Services), By Application (Clinical Diagnostics, Drug Discovery and Other Applications), and By Geography. According to Verifi...

Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research - Vimarsana News

Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research

- The growth of the market can be attributed to a growth in research activities surrounding personalized medicine, increasing investments in R&D by Pharmaceutical and Biotechnology Companies

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis - Vimarsana News

Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis

MINNEAPOLIS, April 15, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma Assay Services to Professional Assay Services, with an expansion of offerings to global academic and clinical institutions, building on 10 years of experience providing services to our global pharma and biotech partners. Bio-Techne's Professional As...